The International Cannabinoid Derived Pharmaceuticals Summit (ICDP) is dedicated to scientific advances and commercial considerations in the therapeutic use of Cannabinoid-Derived Pharmaceuticals.
The International Cannabinoid Derived Pharmaceuticals Summit (ICDP) covers topics such as:
- Designing reliable clinical trials in a frequently changing regulatory environment
- Formulating unique compounds that achieve required responses, that can be delivered effectively
- How to use IP to its maximum potential to build a strong business foundation
- How to form a commercial strategy in a space with an uncertain regulatory environment